HEADER TRANSFERASE 16-FEB-18 6FRX TITLE PKA VARIANT AS AURORA B MIMIC IN COMPLEX WITH A DIANILINOPYRIMIDINE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: PKI-ALPHA,CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 11 MUSCLE/BRAIN ISOFORM; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKACA, PKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS PROTEIN KINASE, SURROGATE MODEL, CATALYTIC DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.A.ENGH,A.A.KAZI REVDAT 1 13-MAR-19 6FRX 0 JRNL AUTH R.A.ENGH,A.A.KAZI JRNL TITL PKA VARIANT AS AURORA B MIMIC IN COMPLEX WITH A JRNL TITL 2 DIANILINOPYRIMIDINE INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 36420 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1822 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.2579 - 4.4171 0.97 2780 147 0.1641 0.1694 REMARK 3 2 4.4171 - 3.5063 0.99 2725 143 0.1540 0.1911 REMARK 3 3 3.5063 - 3.0632 0.99 2665 140 0.1874 0.2459 REMARK 3 4 3.0632 - 2.7832 1.00 2679 141 0.1946 0.2439 REMARK 3 5 2.7832 - 2.5837 1.00 2678 141 0.2026 0.2253 REMARK 3 6 2.5837 - 2.4314 0.99 2641 139 0.1957 0.2481 REMARK 3 7 2.4314 - 2.3096 1.00 2651 140 0.1955 0.2738 REMARK 3 8 2.3096 - 2.2091 0.99 2644 139 0.2051 0.2551 REMARK 3 9 2.2091 - 2.1240 1.00 2657 140 0.2175 0.2477 REMARK 3 10 2.1240 - 2.0507 1.00 2632 139 0.2293 0.2710 REMARK 3 11 2.0507 - 1.9866 0.99 2608 137 0.2638 0.3408 REMARK 3 12 1.9866 - 1.9298 1.00 2654 139 0.2920 0.2988 REMARK 3 13 1.9298 - 1.8790 0.98 2584 137 0.3469 0.4062 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3008 REMARK 3 ANGLE : 0.901 4063 REMARK 3 CHIRALITY : 0.051 423 REMARK 3 PLANARITY : 0.005 518 REMARK 3 DIHEDRAL : 13.088 1775 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FRX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200008836. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36422 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 46.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PKA-AU6 AT 10MG/ML IN 25MM BISTRIS/HCL REMARK 280 (PH7.0), 150MM KCL, 1.5MM OCTANOYL-N-METHYLGLUCAMIDE AND 0.8MM REMARK 280 PKI WAS EQUILIBRATED AGAINST 12-26% (V/V) METHANOL., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.37150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.24200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.89200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.24200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.37150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.89200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 GLY A 320 REMARK 465 PRO A 321 REMARK 465 GLY A 322 REMARK 465 ASP A 323 REMARK 465 THR A 324 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 12 CG CD OE1 NE2 REMARK 470 GLU A 13 CG CD OE1 OE2 REMARK 470 LYS A 16 CG CD CE NZ REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 723 O HOH A 738 2.12 REMARK 500 O HOH A 725 O HOH A 742 2.16 REMARK 500 O HIS B 23 O HOH B 101 2.18 REMARK 500 O HOH A 516 O HOH A 683 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 112 -163.31 -128.34 REMARK 500 ASP A 166 35.13 -148.85 REMARK 500 ASP A 184 100.40 62.73 REMARK 500 PHE A 185 30.34 -98.82 REMARK 500 LEU A 273 48.64 -85.13 REMARK 500 ASN A 326 39.66 -98.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E3Z A 401 DBREF 6FRX A 0 350 UNP P17612 KAPCA_HUMAN 1 351 DBREF 6FRX B 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQADV 6FRX ARG A 47 UNP P17612 LYS 48 CONFLICT SEQADV 6FRX GLN A 95 UNP P17612 LEU 96 CONFLICT SEQADV 6FRX LEU A 120 UNP P17612 MET 121 CONFLICT SEQADV 6FRX ALA A 123 UNP P17612 VAL 124 CONFLICT SEQADV 6FRX LYS A 181 UNP P17612 GLN 182 CONFLICT SEQADV 6FRX ALA A 183 UNP P17612 THR 184 CONFLICT SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE ARG THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE GLN GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL LEU GLU TYR ALA PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE LYS SEQRES 15 A 351 VAL ALA ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 B 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 B 20 ARG ARG ASN ALA ILE HIS ASP MODRES 6FRX SEP A 139 SER MODIFIED RESIDUE MODRES 6FRX TPO A 197 THR MODIFIED RESIDUE MODRES 6FRX SEP A 338 SER MODIFIED RESIDUE HET SEP A 139 10 HET TPO A 197 11 HET SEP A 338 10 HET E3Z A 401 26 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM E3Z ~{N}-[3-[(5-CHLORANYL-2-PHENYLAZANYL-PYRIMIDIN-4-YL) HETNAM 2 E3Z AMINO]PHENYL]PROP-2-ENAMIDE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 E3Z C19 H16 CL N5 O FORMUL 4 HOH *261(H2 O) HELIX 1 AA1 GLN A 12 SER A 32 1 21 HELIX 2 AA2 HIS A 39 ASP A 41 5 3 HELIX 3 AA3 LYS A 76 LEU A 82 1 7 HELIX 4 AA4 GLN A 84 GLN A 96 1 13 HELIX 5 AA5 GLU A 127 GLY A 136 1 10 HELIX 6 AA6 SEP A 139 LEU A 160 1 22 HELIX 7 AA7 LYS A 168 GLU A 170 5 3 HELIX 8 AA8 THR A 201 LEU A 205 5 5 HELIX 9 AA9 ALA A 206 LEU A 211 1 6 HELIX 10 AB1 LYS A 217 GLY A 234 1 18 HELIX 11 AB2 GLN A 242 GLY A 253 1 12 HELIX 12 AB3 SER A 262 LEU A 273 1 12 HELIX 13 AB4 VAL A 288 ASN A 293 1 6 HELIX 14 AB5 HIS A 294 ALA A 298 5 5 HELIX 15 AB6 ASP A 301 GLN A 307 1 7 HELIX 16 AB7 THR B 6 ALA B 12 1 7 SHEET 1 AA1 5 PHE A 43 THR A 51 0 SHEET 2 AA1 5 ARG A 56 HIS A 62 -1 O LEU A 59 N ARG A 47 SHEET 3 AA1 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 AA1 5 ASN A 115 GLU A 121 -1 O LEU A 120 N ALA A 70 SHEET 5 AA1 5 LEU A 106 LYS A 111 -1 N PHE A 108 O VAL A 119 SHEET 1 AA2 2 LEU A 162 ILE A 163 0 SHEET 2 AA2 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AA3 2 LEU A 172 ILE A 174 0 SHEET 2 AA3 2 ILE A 180 VAL A 182 -1 O LYS A 181 N LEU A 173 LINK C PHE A 138 N SEP A 139 1555 1555 1.33 LINK C SEP A 139 N GLU A 140 1555 1555 1.32 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 SITE 1 AC1 14 LEU A 49 THR A 51 ALA A 70 GLU A 121 SITE 2 AC1 14 TYR A 122 ALA A 123 GLY A 126 GLU A 170 SITE 3 AC1 14 LEU A 173 PHE A 327 HOH A 528 HOH A 653 SITE 4 AC1 14 HOH A 674 ARG B 18 CRYST1 58.743 77.784 96.484 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017023 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012856 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010364 0.00000